In our recent article with BioPharma Dive, Emergent's Shelly Buhay, Director of MS&T and Dan Perrin, Director of Manufacturing discuss four essential steps for an efficient tech transfer when working with a CDMO.
When developing a new drug product, quality, safety and timing are critical. A Contract Development and Manufacturing Organization (CDMO) can be a valuable partner to help mitigate risks, avoid missteps and control costs in the process. But the success of the partnership revolves around a key step: the technology transfer.